Akari Therapeutics (AKTX) Net Cash Flow Growth (1y) (2015 - 2026)
Akari Therapeutics (AKTX) Net Cash Flow Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 198.34% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 467.41% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14,223.53% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 453.08% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | -125.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14,223.53% |
| Dec 31, 2025 | 8,963.33% |
| Sep 30, 2025 | 88.41% |
| Jun 30, 2025 | -95.64% |
| Mar 31, 2025 | 99.33% |
| Dec 31, 2024 | 103.36% |
| Sep 30, 2024 | 21.07% |
| Jun 30, 2024 | 165.16% |
| Mar 31, 2024 | -51.68% |
| Dec 31, 2020 | 355.64% |
| Sep 30, 2020 | -120.19% |
| Jun 30, 2020 | 242.63% |
| Mar 31, 2020 | 452.99% |
| Mar 31, 2016 | -276.30% |
| Dec 31, 2015 | -405.38% |
| Sep 30, 2015 | 1,991.18% |
| Jun 30, 2015 | 38.89% |
| Mar 31, 2015 | -132.22% |